Fluoride: Page 58

Treatment approaches for patients at risk of osteonecrosis
By Rabia Mughal
Bisphosphonate-related osteonecrosis of the jaw is a relatively new condition triggered by increased use of bisphosphonate-based drugs. What do dental professionals need to know when dealing with patients at risk of this condition?
September 27, 2009
2009 06 04 14 09 47 485 Drb How To Bug
Lawsuit blames fentanyl lollipops for tooth decay
By DrBicuspid.com staff writers
A Texas man is suing Cephalon, alleging that the company's Actiq fentanyl lollipops -- prescribed as a painkiller for cancer patients -- rotted his teeth.
September 16, 2009
Time to rethink antimicrobials?
By Rochelle Sharpe
BOSTON - Despite concerns of antibiotic overuse and superresistant biofilms, systemic disease experts speaking at the American Academy of Periodontology meeting this week said that dentists should not be so reluctant to prescribe antibiotics for patients with severe gum disease.
September 16, 2009
2009 01 29 16 57 06 752 Boston 70
Merck lawsuit over Fosamax ends in mistrial
By Reuters Health
NEW YORK (Reuters), Sep 11 - A lawsuit alleging that Merck & Co.'s osteoporosis drug Fosamax caused jaw damage ended in a mistrial on Friday.
September 10, 2009
2007 07 16 11 33 13 706
U.K. hygienists may be allowed to supply meds
By DrBicuspid.com staff writers
Hygienists and dental therapists would be allowed to administer prescription medicines under a proposal being considered by the U.K. government.
September 9, 2009
Jury struggles to reach verdict in Fosamax case
By DrBicuspid.com staff writers
U.S. District Judge John Keenan has told the jury in the Merck Fosamax lawsuit case in New York to keep deliberating, despite the panel's claim that it can't reach a decision.
September 8, 2009
Jurors weigh jaw risk of osteoporosis drug Fosamax
By Reuters Health
NEW YORK (Reuters), Sep 3 - Jurors heard sharply different closing arguments on Wednesday in a trial over whether or not Merck & Co.'s Fosamax drug treatment for osteoporosis caused a Florida woman's jaw damage.
September 2, 2009
2008 08 29 15 39 44 564 Justice Scale 70
Lawyer recommends reporting drug-induced xerostomia to FDA
By DrBicuspid.com staff writers
Dentists should report cases of xerostomia caused by medications to the FDA, Edwin Zinman, D.D.S., J.D., told attendees at the World Congress of Minimally Invasive Dentistry annual meeting.
August 18, 2009
OraPharma offers dental students Arestin training
By DrBicuspid.com staff writers
OraPharma recently renewed the Arestin Student Access Program and created a new Professional Affairs Team to provide field support and instructor training for the program.
August 12, 2009
New osteoporosis drug may avoid osteonecrosis
By DrBicuspid.com staff writers
Denosumab, an investigational new drug for osteoporosis, increased patients' bone density without causing osteonecrosis of the jaw in a new study.
August 11, 2009
Merck denies Fosamax caused woman's ONJ
By DrBicuspid.com staff writers
Merck said it will "vigorously defend itself" in the first of what is expected to be several liability trials involving the company's osteoporosis drug Fosamax.
August 10, 2009
Glibenclamide can discolor teeth in children with neonatal diabetes
By Reuters Health
NEW YORK (Reuters Health), Aug 10 - Glibenclamide (glyburide) use has been associated with tooth discoloration in at least five children treated for neonatal diabetes, according to a report in the August issue of Diabetes Care.
August 9, 2009
2007 07 16 11 33 13 706
Previous Page
Page 58 of 61
Next Page